More recently, Lv et al. used a VEGFR-1 (Flt-1)-targeting peptide called SP5.2 (NGYEIEWYSWVTHGMY) fused with tTF in Balb/c mice harboring sarcoma 180 and reported 70% tumor inhibition [57]. This evidence concerns the gene RHOH and neoplasm.